HG-1142

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1142

Drug Alias NameCT-58 modulator (Human Genome Sciences)CTGF-L modulator (Human Genome Sciences)WISP2 modulator (Human Genome Sciences)CCN5 modulator (Human Genome Sciences)Wnt-1 induced signal pathway protein 2 modulator (Human Genome Sciences) +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionConnective tissue growth factor modulators

TargetsConnective tissue growth factor

Therapy Area/IndicationsBone DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsBone DiseasesNeoplasms

Other Information

ATC CodeN/A